New report shows total quantity of antibiotics sold for livestock remains at the lowest level to date.
Sales of veterinary antibiotics in the UK remain at the lowest level recorded a new report published today shows (18 November).
This announcement is positive news for public health, food security, and the economy and reflects the sustained efforts to reduce antibiotic use across the farming sector. Avoiding unnecessary antibiotic usage in humans and animals is crucial to slowing the development of antibiotic resistance, which is one of the biggest global health challenges in the world today.
The Veterinary Antimicrobial Resistance and Sales Surveillance (VARRS) Report published by the Veterinary Medicines Directorate (VMD) shows the UK remains one of the lowest prescribers of veterinary antibiotics in Europe with a 57% decrease in antibiotic sales for livestock and has achieved some of the biggest reductions in AMR across Europe in the last decade
Significantly, recent data published earlier this year from the Animal Plant and Health Agency (APHA) and VMD reveals a strong link between reduced antibiotic use and reduced antimicrobial resistance in animals. A new addition to this year's report is presenting a decade of clinical surveillance data. In most animal species, there are clear declines in resistance, reflecting the sustained efforts to reduce antibiotic use across the farming sector and keep antibiotics working. This mirrors the overall reduction in AMR carried by healthy animals at slaughter.
AMR occurs when bacteria and other microorganisms evolve to resist antimicrobial drugs like antibiotics, rendering these treatments less effective or even ineffective in animals and people. More than 39 million deaths directly attributable to bacterial AMR will occur between now and 2050.
There has been encouraging progress in companion animals with sustained reductions in antibiotic sales for use in cats and dogs, reflecting efforts to improve stewardship across the sector. These developments are supported by work led by the VMD to close long-standing AMR data gaps in companion animals, having recently launched a pilot with SRUC to generate baseline AMR data in healthy cats and dogs in the UK and identify the best approach for developing national surveillance.
Trout and salmon sectors recorded their lowest usage of antibiotics to date whilst usage within pig and gamebird sectors increased, highlighting the need for renewed collective action to reduce the use of antibiotics in animals. Overall, resistance levels in the UK's poultry sectors remain low. There was an unexpected increase in resistance in E. coli in chickens bred and raised for meat production, despite a decrease in antibiotic use. In contrast, multi-drug resistance and resistance to the highest priority clinically important antibiotics showed no increase.
Abi Seager, Veterinary Medicines Directorate CEO said:
This year's report shows that through the ongoing hard work of vets and farmers across the UK we can make real progress in the fight against AMR.
Overall use of antibiotics in livestock remains at its lowest level and importantly use of the most critical antibiotics for human health remains extremely low. This is reflected in results from our AMR surveillance programmes, which show an encouraging picture of AMR reducing in animals.
Baroness Hayman, Minister for Biosecurity, Borders and Animal Welfare, said:
Through combined efforts across Government and industry we continue to make progress in reducing the use of antibiotic in animals, which is vital for public and animal health.
We remain committed to leading the global fight against antimicrobial resistance and to maintaining our place as one of the lowest users of veterinary antibiotics across Europe, so future generations can benefit.
The Animal and Plant Health Agency (APHA) works jointly with VMD to monitor bacteria in food-producing animals for AMR and provide the surveillance data presented in this report. APHA also provide advice and expertise to vets, farmers and industry groups supporting them to reduce the spread of antibiotic resistance. Alongside, it carries out vital research on AMR to support the UK preparedness to incursion of AMR threats, by being at the forefront of the latest technological developments.
The report covers the first year of the UK's latest National Action Plan on AMR (2024-2029) and shows progress being made against the objectives set out in the Plan.
